The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | L | Antineoplastic and immunomodulating agents | |
| 2 | L01 | Antineoplastic agents | |
| 3 | L01C | Plant alkaloids and other natural products | |
| 4 | L01CE | Topoisomerase 1 (TOP1) inhibitors | |
| 5 | L01CE01 | Topotecan |
| Active Ingredient | Description | |
|---|---|---|
| Topotecan |
Topotecan involves the inhibition of topoisomerase-I, an enzyme intimately involved in DNA replication. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| HYCAMTIN Hard capsule | European Medicines Agency (EU) | MPI, EU: SmPC | |
| HYCAMTIN Powder for concentrate for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
